Advertisement
BHFAP vs CNO
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHFAP is a Hold and CNO is a Buy.
Momentum Indicator for BHFAP turns negative, indicating new downward trend
BHFAP saw its Momentum Indicator move below the 0 level on November 02, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 88 similar instances where the indicator turned negative. In 54 of the 88 cases, the stock moved further down in the following days. The odds of a decline are at 61%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day moving average for BHFAP crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 61%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BHFAP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
The Aroon Indicator for BHFAP entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BHFAP's RSI Indicator exited the oversold zone, 19 of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 50%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for BHFAP just turned positive on November 04, 2026. Looking at past instances where BHFAP's MACD turned positive, the stock continued to rise in 24 of 46 cases over the following month. The odds of a continued upward trend are 52%.
Following a +0.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where BHFAP advanced for three days, in 131 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 45%.
BHFAP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BHFAP's P/B Ratio (0.000) is slightly lower than the industry average of (1.337). P/E Ratio (0.000) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.463). BHFAP has a moderately high Dividend Yield (0.133) as compared to the industry average of (0.047). BHFAP's P/S Ratio (0.000) is slightly lower than the industry average of (1.303).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 71 (best 1 - 100 worst), indicating slightly worse than average price growth. BHFAP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BHFAP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock worse than average.
Momentum Indicator for CNO turns positive, indicating new upward trend
CNO saw its Momentum Indicator move above the 0 level on October 13, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned positive. In 61 of the 85 cases, the stock moved higher in the following days. The odds of a move higher are at 72%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for CNO just turned positive on October 15, 2026. Looking at past instances where CNO's MACD turned positive, the stock continued to rise in 25 of 47 cases over the following month. The odds of a continued upward trend are 53%.
CNO moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CNO crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +4.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNO advanced for three days, in 210 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 184 of 296 cases where CNO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.
Bearish Trend Analysis
The 10-day RSI Indicator for CNO moved out of overbought territory on November 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 25 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 61%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 34 of 68 cases where CNO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 50%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 46%.
CNO broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CNO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.980) is normal, around the industry mean (1.337). P/E Ratio (18.733) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.210) is also within normal values, averaging (0.463). Dividend Yield (0.013) settles around the average of (0.047) among similar stocks. P/S Ratio (1.156) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
BHFAP | CNO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 5 | 46 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 3 Undervalued | 61 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 3 | |
SMR RATING 1..100 | 100 | 94 | |
PRICE GROWTH RATING 1..100 | 71 | 41 | |
P/E GROWTH RATING 1..100 | 100 | 13 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BHFAP's Valuation (3) in the null industry is somewhat better than the same rating for CNO (61) in the Life Or Health Insurance industry. This means that BHFAP’s stock grew somewhat faster than CNO’s over the last 12 months.
CNO's Profit vs Risk Rating (3) in the Life Or Health Insurance industry is significantly better than the same rating for BHFAP (100) in the null industry. This means that CNO’s stock grew significantly faster than BHFAP’s over the last 12 months.
CNO's SMR Rating (94) in the Life Or Health Insurance industry is in the same range as BHFAP (100) in the null industry. This means that CNO’s stock grew similarly to BHFAP’s over the last 12 months.
CNO's Price Growth Rating (41) in the Life Or Health Insurance industry is in the same range as BHFAP (71) in the null industry. This means that CNO’s stock grew similarly to BHFAP’s over the last 12 months.
CNO's P/E Growth Rating (13) in the Life Or Health Insurance industry is significantly better than the same rating for BHFAP (100) in the null industry. This means that CNO’s stock grew significantly faster than BHFAP’s over the last 12 months.
| BHFAP | CNO | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 50% | 2 days ago 61% |
| Stochastic ODDS (%) | 2 days ago 49% | 2 days ago 50% |
| Momentum ODDS (%) | 2 days ago 61% | 2 days ago 72% |
| MACD ODDS (%) | 2 days ago 52% | 2 days ago 53% |
| TrendWeek ODDS (%) | 2 days ago 43% | 2 days ago 61% |
| TrendMonth ODDS (%) | 2 days ago 52% | 2 days ago 61% |
| Advances ODDS (%) | 10 days ago 45% | 2 days ago 63% |
| Declines ODDS (%) | 2 days ago 52% | 6 days ago 46% |
| BollingerBands ODDS (%) | 2 days ago 50% | 2 days ago 59% |
| Aroon ODDS (%) | 2 days ago 55% | 2 days ago 62% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BHFAP’s FA Score shows that 1 FA rating(s) are green while CNO’s FA Score has 2 green FA rating(s).
- BHFAP’s FA Score: 1 green, 4 red.
- CNO’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BHFAP’s TA Score shows that 5 TA indicator(s) are bullish while CNO’s TA Score has 6 bullish TA indicator(s).
- BHFAP’s TA Score: 5 bullish, 4 bearish.
- CNO’s TA Score: 6 bullish, 4 bearish.
Price Growth
BHFAP (@Life/Health Insurance) experienced а +0.08% price change this week, while CNO (@Life/Health Insurance) price change was +0.68% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.54%. For the same industry, the average monthly price growth was +3.46%, and the average quarterly price growth was -0.73%.
Reported Earning Dates
CNO is expected to report earnings on Feb 09, 2027.
Industries' Descriptions
@Life/Health Insurance (+0.54% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
Advertisement
BHFAP and
Correlation & Price change
A.I.dvisor indicates that over the last year, BHFAP has been closely correlated with BHFAO. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if BHFAP jumps, then BHFAO could also see price increases.
| Ticker / NAME | Correlation To BHFAP | 1D Price Change % | ||
|---|---|---|---|---|
| BHFAP | 100% | -1.33% | ||
| BHFAO - BHFAP | 93% Closely correlated | -0.94% | ||
| BHFAN - BHFAP | 90% Closely correlated | -0.68% | ||
| BHFAM - BHFAP | 84% Closely correlated | -0.22% | ||
| BHF - BHFAP | 52% Loosely correlated | +0.93% | ||
| CNO - BHFAP | 20% Poorly correlated | +1.08% | ||
More | ||||
CNO and
Correlation & Price change
A.I.dvisor indicates that over the last year, CNO has been loosely correlated with LNC. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if CNO jumps, then LNC could also see price increases.